Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: health

💠 Japanese researchers have created a “nose” mosquito that can detect odors from tiny droplets of liquid droplets. The research could lead to the creation of Smell-O-Vision for machines and a means of diagnosing early cancer, they say. Japanese researchers have created a “nose” that can detect different odors at the same time. The team used two bubbles, each filled with oil, broken horizontally, to create a squinted figure-eight. They hope to use it to develop an artificial nose in the future.

Researchers have developed a “bionic nose” that can detect odor molecules. The team hopes to use the device as an inexpensive way to diagnose the early stages of illness. Eventually, the team wants to use their bionic nose for cancer and other health issues. They hope to make the device available to the public soon.

Thanks and Enjoy đŸ”„ đŸ”„
- -
đŸŽ„ #BioEngineering #Mosquitoes #Cells.

Sources:
⚉ https://www.nature.com/articles/nature.2014.14904#:~:text=The%20human%20nose%20has%20roughly, report%20today%20in%20Science1.
⚉ https://www.eurekalert.org/pub_releases/2021-01/uot-hdy011121.php.
⚉ https://advances.sciencemag.org/content/7/3/eabd2013

Read more | >

After the New Shepard rocket vehicle carried Jeff Bezos, his brother Mark, Wally Funk and Oliver Daemen into space and its capsule glided safely back to the West Texas desert, the four crewmates emerge safely and are greeted by their jubilant families.

» Subscribe to TODAY: http://on.today.com/SubscribeToTODAY
» Watch the latest from TODAY: http://bit.ly/LatestTODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!
Visit TODAY’s Website: http://on.today.com/ReadTODAY
Find TODAY on Facebook: http://on.today.com/LikeTODAY
Follow TODAY on Twitter: http://on.today.com/FollowTODAY
Follow TODAY on Instagram: http://on.today.com/InstaTODAY

#JeffBezos #BlueOrigin #Space

Read more | >

On the first passenger test flight for his space company Blue Origin, Jeff Bezos blasted into space from West Texas along with his brother Mark Bezos, 82-year-old aviator Wally Funk and 18-year-old physics student Oliver Daemen aboard the rocket New Shepard. NBC’s Tom Costello reports for TODAY from Corn Ranch, Texas.

» Subscribe to TODAY: http://on.today.com/SubscribeToTODAY
» Watch the latest from TODAY: http://bit.ly/LatestTODAY

About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

Connect with TODAY Online!
Visit TODAY’s Website: http://on.today.com/ReadTODAY
Find TODAY on Facebook: http://on.today.com/LikeTODAY
Follow TODAY on Twitter: http://on.today.com/FollowTODAY
Follow TODAY on Instagram: http://on.today.com/InstaTODAY

#BlueOrigin #Bezos #Space

Read more | >

CHAPEL HILL, N.C. – Scientists at the University of North Carolina Gillings School of Global Public Health have developed a vaccine that could be effective against COVID-19, its variants — and a future coronavirus pandemic.

While no one knows which virus may cause the next outbreak, coronaviruses remain a threat after causing the SARS outbreak in 2003 and the global COVID-19 pandemic.

According to a study published June 22 in Science, the vaccine designed at UNC-Chapel Hill protected mice from the current SARS-CoV-2 coronavirus, plus a group of coronaviruses known to make the jump from animals to humans.

Read more | >

All cancers fall into just two categories, according to new research from scientists at Sinai Health, in findings that could provide a new strategy for treating the most aggressive and untreatable forms of the disease.

In new research out this month in Cancer Cell, scientists at the Lunenfeld-Tanenbaum Research Institute (LTRI), part of Sinai Health, divide all cancers into two groups, based on the presence or absence of a protein called the Yes-associated protein, or YAP.

Rod Bremner, senior scientist at the LTRI, said they have determined that all cancers are present with YAP either on or off, and each classification exhibits different drug sensitivities or resistance. YAP plays an important role in the formation of malignant tumours because it is an important regulator and effector of the Hippo signaling pathway.

Read more | >

Something to consider.

“The whole idea of lifestyle choices as something everyone can tap into is misleading, when in fact that choice is constrained by what is available to people,” he said. “This is where policy solutions or investments into these neighborhoods to make up for historical disinvestment becomes so important.”

Summary: The neighborhood you live in could have an impact on your brain and cardiovascular health, a new study reports.

Source: American Heart Association

Liz Harris won’t let anything stop her from walking. Three mornings a week, she descends three flights of stairs and heads to Anacostia Park. It’s a 10-minute walk just to get there. If none of her friends are available, she walks alone. But they worry about her when she does.

“The community is known for crime, and you don’t feel comfortable walking alone,” said Harris, 72, who lives in southeastern Washington, D.C.’s Ward 8. But that’s not her only concern. Unleashed dogs in the park make her wary. The streets along the way are uneven and in disrepair. Heavy traffic can contribute to poor air quality.

Read more | >

NAD Coenzymes, Metabolic Stress, And Novel Preventative And Therapeutic Interventions — Dr. Charles Brenner, Ph.D., City of Hope.

Dr. Charles Brenner Ph.D. is the Alfred E Mann Family Foundation Chair in Diabetes and Cancer Metabolism, and Professor and Chair of the Department of Diabetes & Cancer Metabolism, at the City of Hope Comprehensive Cancer Center (https://www.cityofhope.org/faculty/charles-brenner).

With his Ph.D. in Cancer Biology from Stanford University, Dr. Brenner’s laboratory focuses on disturbances in nicotinamide adenine dinucleotide (NAD), the central catalyst of metabolism, in diseases and conditions of metabolic stress (https://www.cityofhope.org/charles-brenner-lab).

Among his most significant discoveries, Dr. Brenner identified nicotinamide riboside (NR) as a vitamin precursor of NAD, as well as a quantitative metabolomic technology that allowed him to discover that the NAD system is disturbed by many diseases and conditions of metabolic stress, including diabetes and cancer.

Specifically, Dr. Brenner and colleagues have found that in animal models of fatty liver, type 2 diabetes, diabetic and chemotherapeutic neuropathy, central brain injury, heart failure, postpartum and coronavirus infection, the NAD system is disturbed and that in these models, provision of nicotinamide riboside is highly protective.

Dr. Brenner also led the team that conducted the first clinical trial of nicotinamide riboside establishing safe oral availability and has participated in trials establishing safety and potential activities of nicotinamide riboside in clearance of liver fat and depression of common markers of inflammation.

Dr. Brenner continues to research how the NAD system is disregulated as a function of postpartum, coronavirus infection, inflammatory conditions, diabesity and specific malignancies, with the dual goals of defining mechanisms of biological regulation and developing safe preventative and therapeutic interventions for people.

Dr. Brenner’s work over the years been funded by numerous agencies including the Leukemia & Lymphoma Society, the March of Dimes, the Burroughs Wellcome Fund, the Beckman Foundation, the Lung Cancer Research Foundation, the National Institutes of Health, and the National Science Foundation.

Read more | >

Health Innovation Investment For The Future Generations — Dr. Aboubacar Kampo, MD, MPH — Director of Health Programs — UNICEF.

Dr. Aboubacar Kampo, MD, MPH is the Director of Health Programs at UNICEF (UN Headquarters) where he provides strategic leadership, management support and overall direction to UNICEF’s global health program.

UNICEF, also known as the United Nations Children’s Emergency Fund, is a United Nations agency responsible for providing humanitarian and developmental aid to children worldwide. The agency is among the most widespread and recognizable social welfare organizations in the world, with a presence in 192 countries and territories. UNICEF’s activities include providing immunizations and disease prevention, administering treatment for children and mothers with HIV, enhancing childhood and maternal nutrition, improving sanitation, promoting education, and providing emergency relief in response to disasters.

With over 20 years of experience in development aid and humanitarian assistance, Dr. Kampo has worked as a physician/surgeon in hospitals and clinics in rural and urban areas in Africa and Asia and has over 14 years’ experience in senior management position as Country Director, Senior Global Health Advisor, and Chief of Health and Nutrition with International NGOs and United Nations’ Agencies.

Dr. Kampo is a Medical Doctor and Public Health Specialist, passionate about using innovations to address real life community challenges and bridge the gap between communities and stakeholders.

Dr. Kampo had his Medical degree from University of Mali, an MPH (Epidemilogy and Complex Emergency) at Tulane University School of Public Health and Tropical Medicine, and is certified in Health Economics from London School of Hygiene and Tropical Medicine, U. of London.

Read more | >

Summary: Using human stem cells to develop a brain organoid model, researchers were able to show exposure to a common pesticide synergizes with an autism-linked gene mutation. The study provides clear evidence that genetics and environment may combine to disrupt neurodevelopment.

Source: Johns Hopkins University.

Researchers at Johns Hopkins Bloomberg School of Public Health have shown in a brain organoid study that exposure to a common pesticide synergizes with a frequent autism-linked gene mutation.

Read more | >